Weight Loss
Tirzepatide
Bloodwork billed separately — or bring recent labs from your own doctor at no extra cost.
Dual-action weight loss for faster, more sustained results.
Tirzepatide is a dual GLP-1/GIP receptor agonist ; the same active ingredient used in FDA-approved medications for weight management. Instead of working on one hunger pathway, it targets two at once, which is why it outperformed semaglutide in head-to-head clinical trials. Trial participants lost up to 20% of their body weight. One injection, once a week.
Key Benefits: Targets two metabolic pathways (GLP-1 + GIP) for greater efficacy, significantly reduces both appetite and cravings, improves insulin sensitivity and metabolic markers, one injection per week, no daily pills, physician supervised throughout, with dosing adjusted to your response.
Form: Subcutaneous injection
Included: medication · supplies · shipping · provider consultation.
Treatment requires completion of our medical intake and review by a licensed provider before approval. Submitting an intake is not a guarantee of treatment; your provider may adjust or decline therapy based on clinical evaluation.